BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8359216)

  • 1. Binding and activation of plasminogen at the surface of human keratinocytes.
    Reinartz J; Batrla R; Boukamp P; Fusenig N; Kramer MD
    Exp Cell Res; 1993 Sep; 208(1):197-208. PubMed ID: 8359216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor for urokinase-type plasminogen activator of a human keratinocyte line (HaCaT).
    Reinartz J; Link J; Todd RF; Kramer MD
    Exp Cell Res; 1994 Oct; 214(2):486-98. PubMed ID: 7925643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1 beta and tumor necrosis factor-alpha.
    Bechtel MJ; Reinartz J; Rox JM; Inndorf S; Schaefer BM; Kramer MD
    Exp Cell Res; 1996 Mar; 223(2):395-404. PubMed ID: 8601416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dispase-mediated basal detachment of cultured keratinocytes induces urokinase-type plasminogen activator (uPA) and its receptor (uPA-R, CD87).
    Schaefer BM; Reinartz J; Bechtel MJ; Inndorf S; Lang E; Kramer MD
    Exp Cell Res; 1996 Nov; 228(2):246-53. PubMed ID: 8912717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and activation of plasminogen on the surface of osteosarcoma cells.
    Campbell PG; Wines K; Yanosick TB; Novak JF
    J Cell Physiol; 1994 Apr; 159(1):1-10. PubMed ID: 7511144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ; Lee SW; Dichek DA; Ellis V
    J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
    Meissauer A; Kramer MD; Schirrmacher V; Brunner G
    Exp Cell Res; 1992 Apr; 199(2):179-90. PubMed ID: 1531956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.
    Reinartz J; Schaefer B; Bechtel MJ; Kramer MD
    Exp Cell Res; 1996 Feb; 223(1):91-101. PubMed ID: 8635500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin in pericellular proteolysis and cellular invasion.
    Kramer MD; Reinartz J; Brunner G; Schirrmacher V
    Invasion Metastasis; 1994-1995; 14(1-6):210-22. PubMed ID: 7657514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
    Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
    J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2.
    Perides G; Noring R; Klempner MS
    Biochem Biophys Res Commun; 1996 Feb; 219(3):690-5. PubMed ID: 8645243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
    Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P
    EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The topology of plasminogen binding and activation on the surface of human breast cancer cells.
    Andronicos NM; Ranson M
    Br J Cancer; 2001 Sep; 85(6):909-16. PubMed ID: 11556845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pericellular plasmin induces smooth muscle cell anoikis.
    Meilhac O; Ho-Tin-Noé B; Houard X; Philippe M; Michel JB; Anglés-Cano E
    FASEB J; 2003 Jul; 17(10):1301-3. PubMed ID: 12738809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering.
    Gundersen D; Trân-Thang C; Sordat B; Mourali F; Rüegg C
    J Immunol; 1997 Feb; 158(3):1051-60. PubMed ID: 9013942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confluence switch signaling regulates ECM composition and the plasmin proteolytic cascade in keratinocytes.
    Botta A; Delteil F; Mettouchi A; Vieira A; Estrach S; Négroni L; Stefani C; Lemichez E; Meneguzzi G; Gagnoux-Palacios L
    J Cell Sci; 2012 Sep; 125(Pt 18):4241-52. PubMed ID: 22641690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences.
    Kramer MD; Schaefer B; Reinartz J
    Biol Chem Hoppe Seyler; 1995 Mar; 376(3):131-41. PubMed ID: 7612190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmin abrogates alpha v beta 5-mediated adhesion of a human keratinocyte cell line (HaCaT) to vitronectin.
    Reinartz J; Schäfer B; Batrla R; Klein CE; Kramer MD
    Exp Cell Res; 1995 Oct; 220(2):274-82. PubMed ID: 7556434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrinsic plasminogen activator: a new principle in fibrinolysis.
    Lijnen HR
    Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.
    Plow EF; Freaney DE; Plescia J; Miles LA
    J Cell Biol; 1986 Dec; 103(6 Pt 1):2411-20. PubMed ID: 3023400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.